Gelomics is an Australian deep-tech biotechnology company revolutionising drug development by replacing animal testing with human-relevant 3D cell culture technologies. Headquartered in Brisbane, Gelomics designs and manufactures cutting-edge platforms that enable the growth of functional human tissues in vitro. Our integrated LunaXTM System—combining proprietary hydrogels, advanced photopolymerisation devices, and AI-driven software—empowers pharmaceutical and research institutions worldwide to develop safer, more effective therapies, faster. Gelomics serves over 23 international markets across North America, Europe, Asia-Pacific, and the Middle East, with clients including leading academic institutions, CROs, and multinational pharmaceutical companies. Our mission is to accelerate life science innovation through ethical, scalable, and predictive non-animal models.